AustCham China has entered into a cooperation agreement with FOSUN Pharma, the exclusive distributor in Mainland China for the world-leading Pfizer BioNTech COVID-19 Vaccine developed in Germany. https://www.cvdvaccine.com/​

With limited doses available, AustCham member companies, employees and family members can register with AustCham for priority access to the vaccine which will be available once approved for release by the National Medical Products Administration (formerly the CFDA). We anticipate approval to be finalised in the coming weeks.

Along with FOSUN, AustCham will in the coming weeks host a webinar with experts to talk about the vaccine and at that time will be able to give you further details as to how you can be vaccinated. We anticipate being able to offer vaccinations in Beijing, Shanghai, Guangzhou, Shenzhen and Chengdu and all vaccinations will be delivered in approved medical facilities with full access to insurance coverage should your policy allow for it.

You must be a member of AustCham and be registered to access this terrific benefit – for membership enquires email Kristian.ricardo@austcham.org

For any questions regarding this program, please contact nick.coyle@austcham.org

If you are having any issues with the registration system, please contact maddy.myott@austcham.org

Please pre-register now as those who have pre-registered will be given priority. When the vaccine is approved, AustCham will contact each of the pre-registered organisations with further instructions.